The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of anlotinib as first-line treatment and followed by tyrosine kinase inhibitors (TKIs) combined with PD-1 blockades regimen after disease progression for advanced hepatocellular carcinoma (HCC): A real-world exploratory study.
 
Qing-Qing Li
No Relationships to Disclose
 
Sheng-Li Ma
No Relationships to Disclose
 
Lu Zhang
No Relationships to Disclose
 
Xian-Qiang Zhang
No Relationships to Disclose
 
Xiao-Juan Gao
No Relationships to Disclose
 
Yan-Feng Pan
No Relationships to Disclose